Our Vision

ENABLE unique translational platforms that address the key bottlenecks in RM commercialization
INTEGRATE Australia’s strength in stem cell and biomaterials sciences with dynamic business leadership
ENGAGE industry partners, linking to a global nexus of RM commercialization
INTERNATIONALISE Australian RM activities to leading RM powerhouses.

We want to provide opportunities to develop skills in the areas of #clinicaltranslation & commercialisation of #regenerativemedicine. We have an opportunity for a PhD Candidate / #PostDoc to attend #SummerByDesign w/ a travel award. Pls Share widely. ow.ly/h1Wh30nJutg pic.twitter.com/v95m4waz5s

7:00 am · February 18, 2019

CCRM_au

@CCRM_au

Announced this morning: @MTPConnect_AUS to administer the Biomedical Translation Bridge Program w/ @BioCurate, @UniQuestUQ & the Medical Device Partnering Program. The program will support the translation of Australian medical research through to proof of concept stage. twitter.com/MTPConnect_AUS…

10:50 pm · February 17, 2019

CCRM_au

@CCRM_au

The latest global industry briefing showed that 2018 was a year of significant growth in the #regenerativemedicine sector, with a rich & diverse pipeline producing positive data & attracting the attention of investors. ow.ly/TBSw30nHQmd #regenmed #stemcells @CCRM_ca pic.twitter.com/bALaEgeSQ4

7:30 pm · February 17, 2019

CCRM_au

@CCRM_au

Summary of key findings from @cynatastemcells CYP-001 preclinical model which examined the efficacy & action of CYP-001 in reference to acute graft versus host disease (#GvHD). #cynatatherapeutics #stemcells #regenmed #regenerativemedicine #organtransplant twitter.com/cynatastemcell…

11:33 pm · February 14, 2019

CCRM_au

@CCRM_au

Australian #RegenMed company @OrthocellLtd report high success rates w/ their #stemcell therapy Ortho-ATI® which is used in the treatment for chronic tendon injuries. Read the full story below on this great Australian success story. twitter.com/OrthocellLtd/s…

11:24 pm · February 14, 2019

CCRM_au

@CCRM_au

As #stemcell therapies move through #clinicaltrials & get closer to the clinic they are giving rise to new challenges around costs & likelihood of reimbursement, bringing to light growing concerns around reimbursement of cell therapies in Aus & globally. ow.ly/tWVs30nH0sf pic.twitter.com/Q60biRTqfm

7:45 am · February 14, 2019

CCRM_au

@CCRM_au

Our Industry Consortium members @cynatastemcells explains 'Graft-versus-host disease' (#GvHD) in this graphic and how they are working towards reducing the high mortality rates associated with #GvHD. #cynatatherapeutics #stemcells twitter.com/cynatastemcell…

10:23 pm · February 13, 2019

CCRM_au

@CCRM_au

Congrats $OCC twitter.com/orthocellltd/s…

5:25 am · February 11, 2019

CCRM_au

@CCRM_au

Today at CCRM Australia, we're celebrating the International Day of Women and Girls in Science! It's a pleasure to be part of building a better today and tomorrow for those in #regenmed. #WomeninSTEMM #WomeninSTEM #WomeninScience pic.twitter.com/N6nd4lYP02

3:10 am · February 11, 2019

CCRM_au

@CCRM_au

We're reflecting back on a great 2018 by remembering our CEO, @sivio12’s trip to #Israel for the #memorandum signing of Israel joining the CCRM network to advance #regenmed both globally and locally. Read more about the collaboration here: ow.ly/bGZp30nknei pic.twitter.com/dB2YukblGC

8:35 am · January 21, 2019

Our Vision

ENABLE unique translational platforms that address the key bottlenecks in RM commercialization

INTEGRATE Australia’s strength in stem cell and biomaterials sciences with dynamic business leadership

ENGAGE industry partners, linking to a global nexus of RM commercialization

INTERNATIONALISE Australian RM activities to leading RM powerhouses.